These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 12839947

  • 1. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT, Chen NY, Franek KJ, Chen WY.
    Cancer Res; 2003 Jul 01; 63(13):3598-604. PubMed ID: 12839947
    [Abstract] [Full Text] [Related]

  • 2. A novel design of targeted endocrine and cytokine therapy for breast cancer.
    Zhang G, Li W, Holle L, Chen N, Chen WY.
    Clin Cancer Res; 2002 Apr 01; 8(4):1196-205. PubMed ID: 11948133
    [Abstract] [Full Text] [Related]

  • 3. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.
    Cancer J; 2000 Apr 01; 6(5):287-93. PubMed ID: 11079167
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
    Cataldo L, Chen NY, Yuan Q, Li W, Ramamoorthy P, Wagner TE, Sticca RP, Chen WY.
    Int J Oncol; 2000 Dec 01; 17(6):1179-85. PubMed ID: 11078803
    [Abstract] [Full Text] [Related]

  • 5. Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.
    Peirce SK, Chen WY.
    Oncogene; 2004 Feb 12; 23(6):1248-55. PubMed ID: 14647416
    [Abstract] [Full Text] [Related]

  • 6. Mouse endostatin inhibits the formation of lung and liver metastases.
    Yoon SS, Eto H, Lin CM, Nakamura H, Pawlik TM, Song SU, Tanabe KK.
    Cancer Res; 1999 Dec 15; 59(24):6251-6. PubMed ID: 10626820
    [Abstract] [Full Text] [Related]

  • 7. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
    Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY.
    Breast Cancer Res Treat; 2008 Sep 15; 111(2):241-50. PubMed ID: 17955362
    [Abstract] [Full Text] [Related]

  • 8. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
    Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M, Sukhatme VP.
    Cancer Res; 1999 Jan 01; 59(1):189-97. PubMed ID: 9892206
    [Abstract] [Full Text] [Related]

  • 9. Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.
    Langenheim JF, Chen WY.
    Breast Cancer Res Treat; 2005 Apr 01; 90(3):281-93. PubMed ID: 15830142
    [Abstract] [Full Text] [Related]

  • 10. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA, Goffin V.
    Oncogene; 2000 Sep 28; 19(41):4695-705. PubMed ID: 11032019
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X, Bookstein R, Wills K, Avanzini J, Tsai V, LaFace D, Terracina G, Shi B, Nielsen LL.
    Cancer Gene Ther; 2001 Dec 28; 8(12):982-9. PubMed ID: 11781661
    [Abstract] [Full Text] [Related]

  • 12. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.
    Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE.
    Clin Cancer Res; 1999 Nov 28; 5(11):3583-93. PubMed ID: 10589775
    [Abstract] [Full Text] [Related]

  • 13. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
    Langenheim JF, Chen WY.
    J Recept Signal Transduct Res; 2009 Nov 28; 29(2):107-12. PubMed ID: 19519175
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
    Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL.
    Proc Natl Acad Sci U S A; 2000 Apr 25; 97(9):4802-7. PubMed ID: 10758166
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, Roni V, Esposito G, Morini M, Albini A, Noonan DM, Ferrantini M, Amadori A, Chieco-Bianchi L.
    Gene Ther; 2002 Jul 25; 9(13):867-78. PubMed ID: 12080381
    [Abstract] [Full Text] [Related]

  • 16. [Research of cloning, expression of human endostatin gene and its inhibition effects to the glioma in vivo].
    Zhang X, Wu J, Fei Z.
    Zhonghua Yi Xue Za Zhi; 2001 Jul 10; 81(13):783-7. PubMed ID: 11798965
    [Abstract] [Full Text] [Related]

  • 17. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y, Johnson F, Engleman EG, Nolan GP.
    Mol Ther; 2001 Feb 10; 3(2):186-96. PubMed ID: 11237675
    [Abstract] [Full Text] [Related]

  • 18. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 19. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
    Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S, Chada S.
    Cancer Res; 2003 Aug 15; 63(16):5105-13. PubMed ID: 12941841
    [Abstract] [Full Text] [Related]

  • 20. Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R.
    Beck MT, Peirce SK, Chen WY.
    Oncogene; 2002 Aug 01; 21(33):5047-55. PubMed ID: 12140755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.